Pooling sputum samples for TB testing using Xpert MTB/RIF Ultra: an innovative cost-effective and efficient approach to enhance access, equity, and coverage of TB-care among poor communities at risk
Background Xpert MTB/RIF Ultra is a rapid diagnostic tool for tuberculosis (TB) and rifampicin resistance. However, its high-cost challenges programmatic operational use in low-resourced settings, where it’s needed the most due to the high burden of TB. This urges for innovative solutions to improve the cost-effectiveness of TB diagnosis. Therefore, here we investigate accuracy and reliability of a sputum samples pooling testing approach using Xpert MTB/RIF Ultra to expand the community-based TB diagnosis. Methods A cross-sectional study was conducted on sputum samples collected from TB-suspected individuals. Initially, samples were tested individually using Xpert MTB/RIF Ultra, followed by retesting pool samples after each four samples were pooled together following pre-established guidelines. Data were analyzed to measure and evaluate the specificity, sensitivity, negative predictive value (NPV), positive predictive value (PPV), and the cost and time savings of this pooling strategy. Results A total of 1,380 sputum samples were included in this study. Our analysis showed that pooled testing for TB was effective, identifying 110 (7.9%) positive cases. This method had high accuracy with 97.5% agreement, 98.1% specificity, 90.4% sensitivity, 77.3% positive predictive value (PPV), and 99.3% negative predictive value (NPV). It also reduced costs by 51.8% (from 12,472 RwF (~ $10.32) to 6005 RwF (~ $4.97) per sample tested) and cut testing time by 38.4% (from 2.50 to 1.54 h per sample tested). A significant difference in CT values before and after pooling was found ( p = 0.00704), though the effect size was small (Cohen’s d = 0.307), indicating limited interpretation implication. Conclusions This study demonstrates that the samples-pooling approach using Xpert MTB/RIF Ultra significantly reduces both costs and testing time in operational settings. This offers a great opportunity to expand the access to molecular TB diagnostic services enhancing health equity among at risk populations in low resources settings. This saving in cost and time, if used properly it will improve quality and accessibility of other health services through integration and resources sharing, particularly during this era of funding cut. The cost-effectiveness of this approach will significantly facilitates implementing community surveys to test seemingly health yet at high-risk asymptomatic individuals.
Hakizayezu, Francois, Mohamed, Nouh Saad, Niyompano, Hosee et al. Pooling sputum samples for TB testing using Xpert MTB/RIF Ultra: an innovative cost-effective and efficient approach to enhance access, equity, and coverage of TB-care among poor communities at risk. // Mycobacteria. – 2025. – DOI: 10.1186/s44350-025-00011-8. – URL: https://www.biomedcentral.com/openurl?doi=10.1186/s44350-025-00011-8
Hakizayezu, Francois, Mohamed, Nouh Saad, Niyompano, Hosee, Niyoyita, Jean Claude, Jerome, Ndayisenga, Niyonsenga, Therese, Kagirimpundu, Genevieuve, Yankurije, Angelique, Muteteri, Beata, Uwayisenga, Pacifique, Uwakijijwe, Bonheur, Kamanzi, Eliane, Gahamanyi, Noel, Gashegu, Misbah, Mukagatare, Isabelle, Migambi, Patrick, Ahmed, Ayman, Ngabonziza, & Jean Claude. S (2025). Pooling sputum samples for TB testing using Xpert MTB/RIF Ultra: an innovative cost-effective and efficient approach to enhance access, equity, and coverage of TB-care among poor communities at risk. Mycobacteria. https://doi.org/10.1186/s44350-025-00011-8
Hakizayezu, et al. “Pooling sputum samples for TB testing using Xpert MTB/RIF Ultra: an innovative cost-effective and efficient approach to enhance access, equity, and coverage of TB-care among poor communities at risk.” Mycobacteria, 2025. doi:10.1186/s44350-025-00011-8.
@article{Hakizayezu2025,
title = {Pooling sputum samples for TB testing using Xpert MTB/RIF Ultra: an innovative cost-effective and efficient approach to enhance access, equity, and coverage of TB-care among poor communities at risk},
author = {Hakizayezu and Francois and Mohamed and Saad, Nouh and Niyompano and Hosee and Niyoyita and Claude, Jean and Jerome and Ndayisenga and Niyonsenga and Therese and Kagirimpundu and Genevieuve and Yankurije and Angelique and Muteteri and Beata and Uwayisenga and Pacifique and Uwakijijwe and Bonheur and Kamanzi and Eliane and Gahamanyi and Noel and Gashegu and Misbah and Mukagatare and Isabelle and Migambi and Patrick and Ahmed and Ayman and Ngabonziza and S., Jean Claude.},
journal = {Mycobacteria},
year = {2025},
doi = {10.1186/s44350-025-00011-8},
url = {https://www.biomedcentral.com/openurl?doi=10.1186/s44350-025-00011-8}
}
Background Diesel exhaust particles (DEP) are a major component of combustion-derived PM_2.5 and contain complex mixtures of organic and inorganic contaminants associated with elemental carbon (black carbon). Diesel particulate matter...
Background Triptolide (TP), a bioactive diterpenoid derived from Tripterygium wilfordii Hook F., exhibits potent anti-inflammatory and immunosuppressive activities but has a narrow therapeutic window and documented toxicities in...
Background Residents living near smelters and abandoned metal mines may experience chronic heavy metal exposure through multiple environmental pathways. Proteomic profiling provides a promising approach for identifying early biological...
Backgrounds Micro- and nanoplastics are associated with metabolic toxicity, but their effects on hepatic cholesterol homeostasis and potential mitigating interventions remain insufficiently characterized. Objectives To characterize...
Background Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants that accumulate in human tissues and may cause prolonged cellular and organ damage. Ferroptosis, an iron-dependent form of regulated cell...